a randomized trial comparing daunorubicin with mitoxantrone in combination with cytarabine in untreated patients with anll should answer whether mitoxantrone is less toxic and whether it should replace daunorubicin in standard induction therapy in anll .
C0011015
daunorubicin
C0023467
anll